Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;116(4):848-849.
doi: 10.14309/ajg.0000000000001008.

Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence

Tianyi Ma  1 , Meng Wu
Affiliations
Comment

Association Between Famotidine Use and Clinical Outcomes in Patients With COVID-19: Assessment of Available Evidence

Tianyi Ma et al. Am J Gastroenterol. 2021 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Guarantor of the article: Tianyi Ma, MD.

Specific author contributions: T.M. and M.W. drafted the manuscript.

Financial support: None to report.

Potential competing interests: None to report.

Comment in

  • Response to Ma and Wu.
    Mather J. Mather J. Am J Gastroenterol. 2021 Apr;116(4):849-850. doi: 10.14309/ajg.0000000000001068. Am J Gastroenterol. 2021. PMID: 33982974 No abstract available.

Comment on

References

    1. Mather JF, Seip RL, McKay RG. Impact of famotidine use on clinical outcomes of hospitalized patients with COVID-19. Am J Gastroenterol 2020;115(10):1617–23. - PMC - PubMed
    1. Lee SW, Ha EK, Yeniova AO, et al. Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: A nationwide cohort study with propensity score matching. Gut 2020. doi: 10.1136/gutjnl-2020-322248. - DOI - PubMed
    1. El-Kurdi B, Khatua B, Rood C, et al. Mortality from coronavirus disease 2019 increases with unsaturated fat and may be reduced by early calcium and albumin supplementation. Gastroenterology 2020;159(3):1015–8.e4. - PMC - PubMed
    1. Cheung KS, Hung IF, Leung WK. Association between famotidine use and COVID-19 severity in Hong Kong: A territory-wide study. Gastroenterology 2020. doi: 10.1053/j.gastro.2020.05.098. - DOI - PMC - PubMed
    1. Freedberg DE, Conigliaro J, Wang TC, et al. Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: A propensity score matched retrospective cohort study. Gastroenterology 2020;159(3):1129–31.e3. - PMC - PubMed